HUP0200096A2 - Szteroid-szulfatáz inhibitorok és alkalmazásuk - Google Patents

Szteroid-szulfatáz inhibitorok és alkalmazásuk

Info

Publication number
HUP0200096A2
HUP0200096A2 HU0200096A HUP0200096A HUP0200096A2 HU P0200096 A2 HUP0200096 A2 HU P0200096A2 HU 0200096 A HU0200096 A HU 0200096A HU P0200096 A HUP0200096 A HU P0200096A HU P0200096 A2 HUP0200096 A2 HU P0200096A2
Authority
HU
Hungary
Prior art keywords
same
steroid sulfatase
sulfatase inhibitors
inhibitors
steroid
Prior art date
Application number
HU0200096A
Other languages
English (en)
Inventor
Shiro Akinaga
Pui-Kai Li
Chikara Murakata
Original Assignee
Duquesne University Of The Holy Ghost
Kyowa Hakko Kogyo Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duquesne University Of The Holy Ghost, Kyowa Hakko Kogyo Co., Ltd. filed Critical Duquesne University Of The Holy Ghost
Publication of HUP0200096A2 publication Critical patent/HUP0200096A2/hu
Publication of HUP0200096A3 publication Critical patent/HUP0200096A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
HU0200096A 1999-01-25 2000-01-24 Steroid sulfatase inhibitors and using the same HUP0200096A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/236,842 US6288050B1 (en) 1997-07-18 1999-01-25 Steroid sulfatase inhibitors and methods for making and using the same

Publications (2)

Publication Number Publication Date
HUP0200096A2 true HUP0200096A2 (hu) 2002-07-29
HUP0200096A3 HUP0200096A3 (en) 2003-01-28

Family

ID=22891204

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200096A HUP0200096A3 (en) 1999-01-25 2000-01-24 Steroid sulfatase inhibitors and using the same

Country Status (16)

Country Link
US (2) US6288050B1 (hu)
EP (1) EP1147124B1 (hu)
JP (1) JP3913475B2 (hu)
KR (1) KR20010108127A (hu)
CN (1) CN1159337C (hu)
AT (1) ATE338056T1 (hu)
AU (1) AU768677C (hu)
BR (1) BR0008437A (hu)
CA (1) CA2361168A1 (hu)
DE (1) DE60030410T2 (hu)
ES (1) ES2272256T3 (hu)
HU (1) HUP0200096A3 (hu)
MX (1) MXPA01007506A (hu)
NO (1) NO318836B1 (hu)
NZ (1) NZ512923A (hu)
WO (1) WO2000043408A2 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
JP2000309599A (ja) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
US6953785B2 (en) 2000-04-24 2005-10-11 Kyowa Hakko Kogyo Co., Ltd. Estra-1,3,5(10)-triene derivatives
AU2256702A (en) * 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
WO2003039466A2 (en) * 2001-11-06 2003-05-15 Applied Research Systems Ars Holding N.V. Method of treating estrogen responsive breast cancer
CA2466106A1 (en) * 2001-11-06 2003-05-15 Applied Research Systems Ars Holding N.V. Methods of treating endometreosis
US20040042416A1 (en) * 2002-08-27 2004-03-04 Ngo Chuong Ngoc Virtual Local Area Network auto-discovery methods
AU2003272964A1 (en) * 2002-10-09 2004-05-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for hormone-dependent cancer
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
PL378577A1 (pl) * 2003-03-24 2006-05-02 Sterix Limited Pochodne estrogenu jako inhibitory sulfatazy steroidowej
WO2005095437A1 (ja) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. ステロイド誘導体の製造法
CA2931313C (en) 2013-11-21 2022-04-05 Marquette University Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
JP2022506513A (ja) * 2018-11-01 2022-01-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン媒介性疾患の処置のための化合物、組成物、および方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (hu)
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5763492A (en) 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
US5763432A (en) 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use

Also Published As

Publication number Publication date
NO20013632L (no) 2001-09-03
NZ512923A (en) 2003-01-31
WO2000043408A2 (en) 2000-07-27
NO20013632D0 (no) 2001-07-24
US6399595B1 (en) 2002-06-04
DE60030410D1 (de) 2006-10-12
MXPA01007506A (es) 2003-06-24
AU2625900A (en) 2000-08-07
CN1159337C (zh) 2004-07-28
AU768677B2 (en) 2003-12-18
JP3913475B2 (ja) 2007-05-09
KR20010108127A (ko) 2001-12-07
ATE338056T1 (de) 2006-09-15
WO2000043408A3 (en) 2000-11-30
AU768677C (en) 2004-11-11
US6288050B1 (en) 2001-09-11
JP2002535340A (ja) 2002-10-22
NO318836B1 (no) 2005-05-09
ES2272256T3 (es) 2007-05-01
CN1340056A (zh) 2002-03-13
CA2361168A1 (en) 2000-07-27
HUP0200096A3 (en) 2003-01-28
EP1147124A2 (en) 2001-10-24
BR0008437A (pt) 2001-10-30
EP1147124B1 (en) 2006-08-30
DE60030410T2 (de) 2007-08-30

Similar Documents

Publication Publication Date Title
PL356066A1 (en) Caspase inhibitors and uses thereof
AU3620600A (en) Skin-marking devices and their use
IL147296A0 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents
IL146223A0 (en) Steroid derivatives
GB2365185A8 (en) Systems and methods for trading
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
AU7065200A (en) Putting improvement devices and methods
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0200096A3 (en) Steroid sulfatase inhibitors and using the same
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
GB2352523B (en) Fluid-gauging systems and methods
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
HK1049329A1 (en) Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors.
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
GB0318112D0 (en) ›-Secretase enzyme compositions and methods
GB0021915D0 (en) Creating and managing E-receipts
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
GB0009204D0 (en) Headstones and the like
GB9929581D0 (en) Comjpositions and their use
GB9911606D0 (en) Composition and use
GB9923117D0 (en) Insect-paper and methods for its formation and use